344 related articles for article (PubMed ID: 15729075)
1. Small-diameter blood vessels engineered with bone marrow-derived cells.
Cho SW; Lim SH; Kim IK; Hong YS; Kim SS; Yoo KJ; Park HY; Jang Y; Chang BC; Choi CY; Hwang KC; Kim BS
Ann Surg; 2005 Mar; 241(3):506-15. PubMed ID: 15729075
[TBL] [Abstract][Full Text] [Related]
2. Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow-derived cells and a hybrid biodegradable polymer scaffold.
Cho SW; Jeon O; Lim JE; Gwak SJ; Kim SS; Choi CY; Kim DI; Kim BS
J Vasc Surg; 2006 Dec; 44(6):1329-40. PubMed ID: 17145438
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor.
Cho SW; Lim JE; Chu HS; Hyun HJ; Choi CY; Hwang KC; Yoo KJ; Kim DI; Kim BS
J Biomed Mater Res A; 2006 Feb; 76(2):252-63. PubMed ID: 16265638
[TBL] [Abstract][Full Text] [Related]
4. Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices.
Cho SW; Park HJ; Ryu JH; Kim SH; Kim YH; Choi CY; Lee MJ; Kim JS; Jang IS; Kim DI; Kim BS
Biomaterials; 2005 May; 26(14):1915-24. PubMed ID: 15576165
[TBL] [Abstract][Full Text] [Related]
5. Tissue engineering of heart valves in vivo using bone marrow-derived cells.
Kim SS; Lim SH; Hong YS; Cho SW; Ryu JH; Chang BC; Choi CY; Kim BS
Artif Organs; 2006 Jul; 30(7):554-7. PubMed ID: 16836737
[TBL] [Abstract][Full Text] [Related]
6. Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery.
Cho SW; Kim IK; Kang JM; Song KW; Kim HS; Park CH; Yoo KJ; Kim BS
Tissue Eng Part A; 2009 Apr; 15(4):901-12. PubMed ID: 18783324
[TBL] [Abstract][Full Text] [Related]
7. Tissue-engineered blood vessels with endothelial nitric oxide synthase activity.
Lim SH; Cho SW; Park JC; Jeon O; Lim JM; Kim SS; Kim BS
J Biomed Mater Res B Appl Biomater; 2008 May; 85(2):537-46. PubMed ID: 18076094
[TBL] [Abstract][Full Text] [Related]
8. Development and in vivo validation of tissue-engineered, small-diameter vascular grafts from decellularized aortae of fetal pigs and canine vascular endothelial cells.
Ma X; He Z; Li L; Liu G; Li Q; Yang D; Zhang Y; Li N
J Cardiothorac Surg; 2017 Nov; 12(1):101. PubMed ID: 29178903
[TBL] [Abstract][Full Text] [Related]
9. [Constructing a small-diameter decellularized vascular graft pre-loaded with bFGF].
Zhou M; Liu C; Wei Z; Liu Z; Jiang X; Qiao T; Ran F
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Mar; 22(3):370-5. PubMed ID: 18396724
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic changes of acellularized xenogenic carotid vascular grafts implanted in a pig-to-goat model.
Kim WS; Seo JW; Rho JR; Kim WG
Int J Artif Organs; 2007 Jan; 30(1):44-52. PubMed ID: 17295192
[TBL] [Abstract][Full Text] [Related]
11. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo.
Matsumura G; Miyagawa-Tomita S; Shin'oka T; Ikada Y; Kurosawa H
Circulation; 2003 Oct; 108(14):1729-34. PubMed ID: 12963635
[TBL] [Abstract][Full Text] [Related]
12. In situ tissue regeneration using a novel tissue-engineered, small-caliber vascular graft without cell seeding.
Yokota T; Ichikawa H; Matsumiya G; Kuratani T; Sakaguchi T; Iwai S; Shirakawa Y; Torikai K; Saito A; Uchimura E; Kawaguchi N; Matsuura N; Sawa Y
J Thorac Cardiovasc Surg; 2008 Oct; 136(4):900-7. PubMed ID: 18954628
[TBL] [Abstract][Full Text] [Related]
13. The development of a tissue-engineered artery using decellularized scaffold and autologous ovine mesenchymal stem cells.
Zhao Y; Zhang S; Zhou J; Wang J; Zhen M; Liu Y; Chen J; Qi Z
Biomaterials; 2010 Jan; 31(2):296-307. PubMed ID: 19819544
[TBL] [Abstract][Full Text] [Related]
14. Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly (propylene carbonate) graft.
Zhang J; Qi H; Wang H; Hu P; Ou L; Guo S; Li J; Che Y; Yu Y; Kong D
Artif Organs; 2006 Dec; 30(12):898-905. PubMed ID: 17181830
[TBL] [Abstract][Full Text] [Related]
15. Superior late patency of small-diameter Dacron grafts seeded with omental microvascular cells: an experimental study.
Pasic M; Müller-Glauser W; von Segesser LK; Lachat M; Mihaljevic T; Turina MI
Ann Thorac Surg; 1994 Sep; 58(3):677-83; discussion 683-4. PubMed ID: 7944688
[TBL] [Abstract][Full Text] [Related]
16. Decellularized native and engineered arterial scaffolds for transplantation.
Dahl SL; Koh J; Prabhakar V; Niklason LE
Cell Transplant; 2003; 12(6):659-66. PubMed ID: 14579934
[TBL] [Abstract][Full Text] [Related]
17. Canine endothelial progenitor cell-lined hybrid vascular graft with nonthrombogenic potential.
He H; Shirota T; Yasui H; Matsuda T
J Thorac Cardiovasc Surg; 2003 Aug; 126(2):455-64. PubMed ID: 12928644
[TBL] [Abstract][Full Text] [Related]
18. Tissue-engineered blood vessel graft produced by self-derived cells and allogenic acellular matrix: a functional performance and histologic study.
Yang D; Guo T; Nie C; Morris SF
Ann Plast Surg; 2009 Mar; 62(3):297-303. PubMed ID: 19240529
[TBL] [Abstract][Full Text] [Related]
19. Long-term patency of small-diameter vascular graft made from fibroin, a silk-based biodegradable material.
Enomoto S; Sumi M; Kajimoto K; Nakazawa Y; Takahashi R; Takabayashi C; Asakura T; Sata M
J Vasc Surg; 2010 Jan; 51(1):155-64. PubMed ID: 19954921
[TBL] [Abstract][Full Text] [Related]
20. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling.
Roh JD; Sawh-Martinez R; Brennan MP; Jay SM; Devine L; Rao DA; Yi T; Mirensky TL; Nalbandian A; Udelsman B; Hibino N; Shinoka T; Saltzman WM; Snyder E; Kyriakides TR; Pober JS; Breuer CK
Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4669-74. PubMed ID: 20207947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
